Abstract:Background and ObjectivesKetoprofen, a potent nonsteroidal anti-inflammatory drug, is clinically administered as a racemic mixture. One of the possible metabolism routes of ketoprofen is the inversion of the R- to S-enantiomer in the gastrointestinal tract. Ketoprofen, as a weak acid drug, might undergo recirculation through pancreatic/intestinal juices. The aim of the work was to investigate if a plasma-gastrointestinal tract recirculation of ketoprofen could explain its R-to-S chiral inversion after the oral administration of two modified-release formulations: a gastro-resistant delayed-release tablet (Reference) and an extended-release-plus-immediate-release bilayer tablet (Test).MethodsSixteen healthy Caucasian volunteers (eight women and eight men) participated in a ketoprofen bioequivalence study. Both formulations were administered with and without food. In both cases, standard meals were given throughout the experiment. R- and S-enantiomers were measured separately using a validated HPLC–UV chiral method. Mean concentration–time profiles of ketoprofen enantiomers in plasma were obtained for men and women. Area under the plasma concentration–time curve, maximum ketoprofen plasma concentration, and time-to-peak were also computed for both isomers, both modes of administration, and both sexes. S/R concentration ratio was assessed as an indicator of enantiomer chiral inversion rate.ResultsDifferences in the pharmacokinetics of S- and R-ketoprofen enantiomers were found after the Test administration. S-Ketoprofen presented a lower plasma exposure compared to R-enantiomer. However, the S/R concentration ratio increased 1 h (in men) and 2 h (in women) after meal intakes. This was related to pancreatic and/or intestinal and/or biliary secretions of the drug, followed by reabsorption and conversion of the R- to the S-isomer. The lower intestinal pH reported for men would lead to a higher oral bioavailability of the Test formulation and a higher reabsorption of both ketoprofen isomers in this sex. Hence, a higher rise of the S/R concentration ratio could be observed in men. No significant differences between isomers exposure were detected in both sexes after the Reference administration. Different lag times were observed after fed and fasting administration of this formulation; however, drug absorption coincided with food ingestion. Then, drug recirculation affected the S/R ratio from the beginning of drug exposure, minimizing the difference between isomers disposition.ConclusionsR-to-S conversion rate could be mainly associated with several passages of the drug through the intestinal mucosa. The concentration–time profiles of ketoprofen in plasma after the administration of both formulations evidenced R-to-S conversion of recirculating drug following meal intakes.

Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects

Stereoselective Behavior of a Novel Biodegradable Racemic Ketoprofen Injectable Implant in Rats

CHIRAL RP-HPLC ASSAY FOR PROPAFENONE ENANTIOMERS IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN VITRO METABOLISM

[Stereoselective Determination of Propranolol Enantiomer in Transgenic Cell Lines Expressing Human Cytochrome P450].

Study on bioequivalence of cilostazol table in healthy volunteers

Monitoring Release of Ketoprofen Enantiomers from Biodegradable Poly(D,L-Lactide-Co-Glycolide) Injectable Implants

Determination of R(+)- and S(-)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humans

Pharmacokinetics of Ibuprofen Enantiomers in Rats after Intravenous and Oral Administration of Ibuprofen Arginate.

Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers

Study on the stereoselectivity of racemic propranolol glucuronidation metabolism

Mechanism of Reductive Metabolism and Chiral Inversion of Proton Pump Inhibitors

Contribution of UGT Enzymes to Human Drug Metabolism Stereoselectivity: A Case Study of Medetomidine, RO5263397, Propranolol, and Testosterone

A Chiral LC-MS/MS Method for the Enantioselective Determination of R-(+)- and S-(-)-pantoprazole in Human Plasma and Its Application to a Pharmacokinetic Study of S-(-)-pantoprazole Sodium Injection.

Stereoselective Pharmacokinetics and Chiral Inversions of Some Chiral Hydroxy Group Drugs

Stereoselective Urinary Excretion of S-(-)- and R-(+)-Propranolol Glucuronide Following Oral Administration of Rs-Propranolol in Chinese Han Subjects

Analysis of Flurbiprofen, Ketoprofen and Etodolac Enantiomers by Pre-Column Derivatization RP-HPLC and Application to Drug–protein Binding in Human Plasma

Stereoselectivity and Interaction Between the Glucuronidation of S-(-)- and R-(+)-Propranolol in Rat Hepatic Microsomes Pretreated with Different Inducers

Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?

Determination of Ibuprofen Enantiomers in Mouse Blood Using Liquid Chromatography–Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study

Pharmacokinetics of Terazosin Enantiomers in Healthy Chinese Male Subjects

Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics